Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH 4-( (6-(4-FLUOROPHENYL)-(1,2,4)TRIAZOLO(4,3-B)(1,2,4)TRIAZIN-3-YL)METHYL) PHENOL
 
Authors :  M. Mctigue, J. Wickersham
Date :  30 Mar 12  (Deposition) - 26 Sep 12  (Release) - 10 Oct 12  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  1.80
Chains :  Asym./Biol. Unit :  A
Keywords :  Transferase (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  J. J. Cui, M. Mctigue, M. Nambu, M. Tran-Dube, M. Pairish, H. Shen, L. Jia, H. Cheng, J. Hoffman, P. Le, M. Jalaie, G. H. Goetz, K. Ryan, N. Grodsky, Y. Deng, M. Parker, S. Timofeevski, B. W. Murray, S. Yamazaki, S. Aguirre, Q. Li, H. Zou, J. Christensen
Discovery Of A Novel Class Of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (C-Met) Protein Kinase Inhibitors And Identification Of The Clinical Candidate 2-(4-(1-(Quinolin-6-Ylmethyl)-1H-[1, 2, 3]Triazolo[4, 5-B]Pyrazin-6-Yl)-1H-Pyrazol-1-Yl)Ethanol (Pf- 04217903) For The Treatment Of Cancer.
J. Med. Chem. V. 55 8091 2012
PubMed-ID: 22924734  |  Reference-DOI: 10.1021/JM300967G

(-) Compounds

Molecule 1 - HEPATOCYTE GROWTH FACTOR RECEPTOR
    ChainsA
    EC Number2.7.10.1
    EngineeredYES
    Expression SystemSPODOPTERA FRUGIPERDA
    Expression System Cell LineSF9
    Expression System CommonFALL ARMYWORM
    Expression System PlasmidPFASTBAC1
    Expression System Taxid7108
    Expression System Vector TypeBACULOVIRUS
    FragmentTYROSINE KINASE DOMAIN, UNP RESIDUES 1051-1348
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymHGF RECEPTOR, HGF/SF RECEPTOR, PROTO-ONCOGENE C-MET, SCATTER FACTOR RECEPTOR, SF RECEPTOR, TYROSINE-PROTEIN KINASE MET

 Structural Features

(-) Chains, Units

  1
Asymmetric/Biological Unit A

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (1, 1)

Asymmetric/Biological Unit (1, 1)
No.NameCountTypeFull Name
1F471Ligand/Ion4-[[6-(4-FLUOROPHENYL)-[1,2,4]TRIAZOLO[4,3-B][1,2,4]TRIAZIN-3-YL]METHYL]PHENOL

(-) Sites  (1, 1)

Asymmetric Unit (1, 1)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREVAL A:1092 , ALA A:1108 , PRO A:1158 , TYR A:1159 , MET A:1160 , ASP A:1164 , ASN A:1167 , ARG A:1208 , MET A:1211 , ALA A:1221 , ASP A:1222 , ALA A:1226 , TYR A:1230 , HOH A:2136BINDING SITE FOR RESIDUE F47 A2345

(-) SS Bonds  (0, 0)

(no "SS Bond" information available for 4AP7)

(-) Cis Peptide Bonds  (0, 0)

(no "Cis Peptide Bond" information available for 4AP7)

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (19, 19)

Asymmetric/Biological Unit (19, 19)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_032485V1092IMET_HUMANDisease (RCCP)786202724AV1092I
02UniProtVAR_032486H1094LMET_HUMANDisease (RCCP)  ---AH1094L
03UniProtVAR_032487H1094RMET_HUMANDisease (RCCP)121913243AH1094R
04UniProtVAR_032488H1094YMET_HUMANDisease (RCCP)121913244AH1094Y
05UniProtVAR_032489H1106DMET_HUMANDisease (RCCP)  ---AH1106D
06UniProtVAR_006286M1131TMET_HUMANDisease (RCCP)121913668AM1131T
07UniProtVAR_032490T1173IMET_HUMANDisease (HCC)121913675AT1173I
08UniProtVAR_006287V1188LMET_HUMANDisease (RCCP)121913669AV1188L
09UniProtVAR_006288L1195VMET_HUMANDisease (RCCP)121913673AL1195V
10UniProtVAR_006289V1220IMET_HUMANDisease (RCCP)121913670AV1220I
11UniProtVAR_006291D1228HMET_HUMANDisease (RCCP)  ---AD1228H
12UniProtVAR_006290D1228NMET_HUMANDisease (RCCP)121913671AD1228N
13UniProtVAR_006292Y1230CMET_HUMANDisease (RCCP)121913246AY1230C
14UniProtVAR_032491Y1230DMET_HUMANDisease (RCCP)  ---AY1230D
15UniProtVAR_006293Y1230HMET_HUMANDisease (RCCP)121913247AY1230H
16UniProtVAR_032492K1244RMET_HUMANDisease (HCC)121913677AK1244R
17UniProtVAR_032493M1250IMET_HUMANDisease (HCC)121913676AM1250I
18UniProtVAR_006294M1250TMET_HUMANDisease (RCCP)121913245AM1250T
19UniProtVAR_064857V1294IMET_HUMANUnclassified  ---AV1294I

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (2, 2)

Asymmetric/Biological Unit (2, 2)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.MET_HUMAN1084-1110  1A:1084-1110
2PROTEIN_KINASE_TYRPS00109 Tyrosine protein kinases specific active-site signature.MET_HUMAN1200-1212  1A:1200-1212

(-) Exons   (7, 7)

Asymmetric/Biological Unit (7, 7)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1cENST000003977521cENSE00001865305chr7:116312446-116312631186MET_HUMAN-00--
1.3cENST000003977523cENSE00001238915chr7:116339125-1163403381214MET_HUMAN1-4004000--
1.6ENST000003977526ENSE00000717722chr7:116371722-116371913192MET_HUMAN401-464640--
1.7ENST000003977527ENSE00000717724chr7:116380004-116380138135MET_HUMAN465-509450--
1.8ENST000003977528ENSE00000717726chr7:116380906-116381079174MET_HUMAN510-567580--
1.9bENST000003977529bENSE00000717728chr7:116395409-116395569161MET_HUMAN568-621540--
1.10ENST0000039775210ENSE00000717730chr7:116397491-116397593103MET_HUMAN621-655350--
1.11bENST0000039775211bENSE00000717732chr7:116397692-116397828137MET_HUMAN656-701460--
1.12aENST0000039775212aENSE00000717735chr7:116398513-116398674162MET_HUMAN701-755550--
1.13bENST0000039775213bENSE00001530016chr7:116399445-116399544100MET_HUMAN755-788340--
1.14ENST0000039775214ENSE00000717791chr7:116403104-116403322219MET_HUMAN789-861730--
1.15aENST0000039775215aENSE00000717803chr7:116409699-116409845147MET_HUMAN862-910490--
1.16ENST0000039775216ENSE00000717811chr7:116411552-116411708157MET_HUMAN911-963530--
1.17ENST0000039775217ENSE00000717833chr7:116411903-116412043141MET_HUMAN963-1010480--
1.18bENST0000039775218bENSE00000717861chr7:116414935-116415165231MET_HUMAN1010-1087781A:1052-108736
1.19ENST0000039775219ENSE00000717879chr7:116417443-11641752381MET_HUMAN1087-1114281A:1087-1114 (gaps)28
1.20ENST0000039775220ENSE00000717895chr7:116418830-116419011182MET_HUMAN1114-1174611A:1114-117461
1.21ENST0000039775221ENSE00000717902chr7:116422042-116422151110MET_HUMAN1175-1211371A:1175-121137
1.22ENST0000039775222ENSE00000717928chr7:116423358-116423523166MET_HUMAN1211-1266561A:1211-126656
1.23ENST0000039775223ENSE00000717937chr7:116435709-116435845137MET_HUMAN1267-1312461A:1267-131246
1.24bENST0000039775224bENSE00000881894chr7:116435941-1164384402500MET_HUMAN1312-1390791A:1312-134534

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:290
 aligned with MET_HUMAN | P08581 from UniProtKB/Swiss-Prot  Length:1390

    Alignment length:294
                                  1061      1071      1081      1091      1101      1111      1121      1131      1141      1151      1161      1171      1181      1191      1201      1211      1221      1231      1241      1251      1261      1271      1281      1291      1301      1311      1321      1331      1341    
           MET_HUMAN   1052 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 1345
               SCOP domains d4ap7a_ A: automated matches                                                                                                                                                                                                                                                                           SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ..hhhhhhhhhhhhhhh.eehhh.eeeeeeeeeee....eeeeeee.----..eeeeee......hhhhhhhhhhhhhhhhhh.........eee.......eeeee.....hhhhhhhh.....hhhhhhhhhhhhhhhhhhhhhh.......hhh.eee.....eee..hhhhh...hhhhh..........hhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhh............hhhhhhhh..........hhhhhhhhhhhh..hhhhh.hhhhhhhhhhhhhhh.. Sec.struct. author
             SAPs(SNPs) (1) ----------------------------------------I-L-----------D------------------------T-----------------------------------------I--------------L------V------------------------I-------H-C-------------R-----I-------------------------------------------I--------------------------------------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ------------------------------------------R-------------------------------------------------------------------------------------------------------------------------------------N-D-------------------T----------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ------------------------------------------Y---------------------------------------------------------------------------------------------------------------------------------------H------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE --------------------------------PROTEIN_KINASE_ATP         -----------------------------------------------------------------------------------------PROTEIN_KINAS------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.18b  PDB: A:1052-1087        --------------------------Exon 1.20  PDB: A:1114-1174 UniProt: 1114-1174               Exon 1.21  PDB: A:1175-1211          -------------------------------------------------------Exon 1.23  PDB: A:1267-1312 UniProt: 1267-1312--------------------------------- Transcript 1 (1)
           Transcript 1 (2) -----------------------------------Exon 1.19 UniProt: 1087-1114------------------------------------------------------------------------------------------------Exon 1.22  PDB: A:1211-1266 UniProt: 1211-1266          ---------------------------------------------Exon 1.24b  PDB: A:1312-1345       Transcript 1 (2)
                4ap7 A 1052 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLL----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 1345
                                  1061      1071      1081      1091      |  - |    1111      1121      1131      1141      1151      1161      1171      1181      1191      1201      1211      1221      1231      1241      1251      1261      1271      1281      1291      1301      1311      1321      1331      1341    
                                                                       1098 1103                                                                                                                                                                                                                                                  

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 1)

Asymmetric/Biological Unit

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 4AP7)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 4AP7)

(-) Gene Ontology  (33, 33)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A   (MET_HUMAN | P08581)
molecular function
    GO:0005524    ATP binding    Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
    GO:0005008    hepatocyte growth factor-activated receptor activity    Combining with hepatocyte growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.
    GO:0016301    kinase activity    Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
    GO:0000166    nucleotide binding    Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004672    protein kinase activity    Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
    GO:0019903    protein phosphatase binding    Interacting selectively and non-covalently with any protein phosphatase.
    GO:0004713    protein tyrosine kinase activity    Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
    GO:0016740    transferase activity    Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
    GO:0004714    transmembrane receptor protein tyrosine kinase activity    Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
biological process
    GO:0048754    branching morphogenesis of an epithelial tube    The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder.
    GO:0008283    cell proliferation    The multiplication or reproduction of cells, resulting in the expansion of a cell population.
    GO:0007166    cell surface receptor signaling pathway    A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
    GO:0001886    endothelial cell morphogenesis    The change in form (cell shape and size) that occurs during the differentiation of an endothelial cell.
    GO:0048012    hepatocyte growth factor receptor signaling pathway    The series of molecular signals generated as a consequence of the hepatocyte growth factor receptor binding to one of its physiological ligands.
    GO:0010507    negative regulation of autophagy    Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
    GO:1901299    negative regulation of hydrogen peroxide-mediated programmed cell death    Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-mediated programmed cell death.
    GO:0018108    peptidyl-tyrosine phosphorylation    The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
    GO:0016310    phosphorylation    The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
    GO:0050918    positive chemotaxis    The directed movement of a motile cell or organism towards a higher concentration of a chemical.
    GO:2001028    positive regulation of endothelial cell chemotaxis    Any process that activates or increases the frequency, rate or extent of endothelial cell chemotaxis.
    GO:0045944    positive regulation of transcription from RNA polymerase II promoter    Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:0006468    protein phosphorylation    The process of introducing a phosphate group on to a protein.
    GO:0071526    semaphorin-plexin signaling pathway    A series of molecular signals generated as a consequence of a semaphorin receptor (composed of a plexin and a neurophilin) binding to a semaphorin ligand.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
    GO:0007169    transmembrane receptor protein tyrosine kinase signaling pathway    A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
cellular component
    GO:0009925    basal plasma membrane    The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005887    integral component of plasma membrane    The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    F47  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 4ap7)
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  4ap7
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  MET_HUMAN | P08581
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  2.7.10.1
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  114550
    Disease InformationOMIM
  605074
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  MET_HUMAN | P08581
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        MET_HUMAN | P085811fyr 1r0p 1r1w 1shy 1ssl 1ux3 2cew 2g15 2rfn 2rfs 2uzx 2uzy 2wd1 2wgj 2wkm 3a4p 3bux 3c1x 3ccn 3cd8 3ce3 3cth 3ctj 3dkc 3dkf 3dkg 3efj 3efk 3f66 3f82 3i5n 3l8v 3lq8 3q6u 3q6w 3qti 3r7o 3rhk 3u6h 3u6i 3vw8 3zbx 3zc5 3zcl 3zxz 3zze 4aoi 4deg 4deh 4dei 4eev 4gg5 4gg7 4iwd 4k3j 4knb 4mxc 4o3t 4o3u 4r1v 4r1y 4xmo 4xyf 5dg5 5eob 5eyc 5eyd 5hlw 5hni 5ho6 5hoa 5hor 5hti 5t3q 5uab 5uad 5uaf

(-) Related Entries Specified in the PDB File

1fyr DIMER FORMATION THROUGH DOMAIN SWAPPING IN THE CRYSTALSTRUCTURE OF THE GRB2-SH2 AC-PYVNV COMPLEX
1r0p CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THEHEPATOCYTE GROWTH FACTOR RECEPTOR C-MET IN COMPLEX WITHTHE MICROBIAL ALKALOID K-252A
1r1w CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THEHEPATOCYTE GROWTH FACTOR RECEPTOR C-MET
1shy THE CRYSTAL STRUCTURE OF HGF BETA-CHAIN IN COMPLEX WITH THESEMA DOMAIN OF THE MET RECEPTOR.
1ssl SOLUTION STRUCTURE OF THE PSI DOMAIN FROM THE MET RECEPTOR
1ux3 3D STRUCTURE PREDICTION OF AMINO ACIDS 25 TO 656 OF HUMAN HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR (MET) RECEPTOR
2cew 3D STRUCTURE PREDICTION OF THE IG2-IG4 DOMAINS OF THE ECTODOMAIN REGION OF THE HUMAN HEPATOCYTE GROWTH FACTOR-SCATTER FACTOR RECEPTOR, MET
2g15 STRUCTURAL CHARACTERIZATION OF AUTOINHIBITED C-MET KINASE
2uzx STRUCTURE OF THE HUMAN RECEPTOR TYROSINE KINASE MET IN COMPLEX WITH THE LISTERIA MONOCYTOGENES INVASION PROTEIN INLB: CRYSTAL FORM I
2uzy STRUCTURE OF THE HUMAN RECEPTOR TYROSINE KINASE MET IN COMPLEX WITH THE LISTERIA MONOCYTOGENES INVASION PROTEIN INLB: LOW RESOLUTION, CRYSTAL FORM II
2wd1 HUMAN C-MET KINASE IN COMPLEX WITH AZAINDOLE INHIBITOR
2wgj X-RAY STRUCTURE OF PF-02341066 BOUND TO THE KINASE DOMAIN OF C-MET
2wkm X-RAY STRUCTURE OF PHA-00665752 BOUND TO THE KINASE DOMAIN OF C-MET
3zxz X-RAY STRUCTURE OF PF-04217903 BOUND TO THE KINASE DOMAIN OF C-MET
3zze CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH N'-((3Z)-4-CHLORO-7-METHYL-2-OXO-1,2- DIHYDRO-3H-INDOL-3-YLIDENE)-2-(4-HYDROXYPHENYL) PROPANOHYDRAZIDE
4aoi CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH 4-(3-((1H-PYRROLO(2,3-B)PYRIDIN-3-YL)METHYL )-(1,2,4)TRIAZOLO(4,3-B)(1,2,4)TRIAZIN-6-YL) BENZONITRILE